p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker
dc.contributor.author | Flak, MB | en_US |
dc.contributor.author | Connell, CM | en_US |
dc.contributor.author | Chelala, C | en_US |
dc.contributor.author | Archibald, K | en_US |
dc.contributor.author | Salako, MA | en_US |
dc.contributor.author | Pirlo, KJ | en_US |
dc.contributor.author | Lockley, M | en_US |
dc.contributor.author | Wheatley, SP | en_US |
dc.contributor.author | Balkwill, FR | en_US |
dc.contributor.author | McNeish, IA | en_US |
dc.date.accessioned | 2016-07-13T11:26:18Z | |
dc.date.available | 2010-07-03 | en_US |
dc.date.issued | 2010-07-03 | en_US |
dc.date.submitted | 2016-07-06T15:14:31.424Z | |
dc.identifier.issn | 1476-4598 | en_US |
dc.identifier.other | 175 | |
dc.identifier.other | 175 | |
dc.identifier.other | 175 | |
dc.identifier.other | 175 | en_US |
dc.identifier.other | 175 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/13470 | |
dc.format.extent | ? - ? | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | MOL CANCER | en_US |
dc.rights | CC-BY | |
dc.subject | HISTONE DEACETYLASE INHIBITOR | en_US |
dc.subject | CLEAR-CELL CARCINOMA | en_US |
dc.subject | RETINOBLASTOMA PROTEIN | en_US |
dc.subject | GENE-EXPRESSION | en_US |
dc.subject | CDK INHIBITORS | en_US |
dc.subject | VALPROIC ACID | en_US |
dc.subject | P21(WAF1/CIP1) EXPRESSION | en_US |
dc.subject | DEPENDENT KINASES | en_US |
dc.subject | DNA-DAMAGE | en_US |
dc.subject | IN-VITRO | en_US |
dc.title | p21 promotes oncolytic adenoviral activity in ovarian cancer and is a potential biomarker | en_US |
dc.type | Article | |
dc.rights.holder | © 2010 Flak et al; licensee BioMed Central Ltd. | |
dc.identifier.doi | 10.1186/1476-4598-9-175 | en_US |
pubs.notes | Not known | en_US |
pubs.volume | 9 | en_US |
qmul.funder | Inflammatory cytokines and oncolytic viruses in ovarian cancer::CRUK | en_US |